The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
Open accessAbstract
Aims: Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal trial investigated the efficacy of digital therapeutics in patients with hypertension not receiving antihypertensive medication. Methods and results: This prospective, open-label, randomized controlled study was performed at 12 sites in Japan. Patients with hypertension [office systolic blood pressure (SBP) 140 to <180 mmHg and 24 h SBP ≥130 mmHg] were randomly assigned 1:1 to the digital therapeutics group (HERB system + standard lifestyle modification) or control group (standard lifestyle modification alone). The primary efficacy endpoint was the mean change in 24 h ambulatory SBP from baseline to 12 weeks; key secondary efficacy endpoints were mean changes in office and home blood pressure (BP) from baseline to 12 weeks. All analyses were conducted in the full analysis set population. Between December 2019 and June 2020, 390 patients were randomly assigned to the digital therapeutics group (n = 199) or control (n = 191) group. Between-group differences in 24-h ambulatory, home, and office SBPs at 12 weeks were −2.4 (95% confidence interval −4.5 to −0.3), −4.3 (−6.7 to −1.9), and −3.6 (−6.2 to −1.0) mmHg, respectively. No major programme-related safety events occurred up to 24 weeks. Conclusion: The HERB-DH1 pivotal study showed the superiority of digital therapeutics compared with standard lifestyle modification alone to reduce 24-h ambulatory, home, and office BPs in the absence of antihypertensive medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755 · cited 2×
“In a meta-analysis of randomized controlled trials of antihypertensive treatment, a 10 mmHg reduction in office SBP was associated with a 20% reduction in the risk of major cardiovascular events, a 17% reduction in the risk of coronary heart disease, a 27% reduction in the risk of stroke, a 28% reduction in the risk o…”
BackgroundResultHigh blood pressure and cardiovascular disease
Fuchs, F. D., & Whelton, P. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14240 · Cited by 1,948 · cited 1×
“Hypertension, especially uncontrolled hypertension, has a significant negative impact on cardiovascular morbidity and mortality.(1,2) In fact, high systolic blood pressure (SBP) is the leading modifiable contributor to the worldwide cardiovascular disease burden.”
BackgroundKario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari, M., Murata, M., Kuroda, T., Schwartz, J. E., & Shimada, K. (2003) · Circulation · doi:10.1161/01.cir.0000056521.67546.aa · Cited by 1,250
Self-citationPrognostic accuracy of day versus night ambulatory blood pressure: a cohort study
Boggia, J., Li, Y., Thijs, L., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Kuznetsova, T., Torp-Pedersen, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61538-4 · Cited by 887
Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., Earle, K., George, J., Godwin, M., Green, B. B., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002389 · Cited by 658
Nonadherence to antihypertensive drugs: A systematic review and meta-analysis
Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017) · Medicine · doi:10.1097/md.0000000000005641 · Cited by 525
Kario, K., Hoshide, S., Mizuno, H., Kabutoya, T., Nishizawa, M., Yoshida, T., Abe, H., Katsuya, T., Fujita, Y., Okazaki, O., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.049730 · Cited by 324
Self-citationPersell, S. D., Peprah, Y. A., Lipiszko, D., Lee, J. Y., Li, J. J., Ciolino, J. D., Karmali, K. N., & Sato, H. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0255 · Cited by 185
Cited by
Kario, K., Tomitani, N., Wang, T.-D., Park, S., Li, Y., Shin, J., Tsoi, K., Chen, C.-H., Cheng, H.-M., Siddique, S., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01397-6 · Cited by 40
Self-citationLatest hypertension research to inform clinical practice in Asia
Kario, K., Mogi, M., & Hoshide, S. (2022) · Hypertension Research · doi:10.1038/s41440-022-00874-8 · Cited by 32
Self-citation
Metadata
- Authors
- Kario, K., Nomura, A., Harada, N., Okura, A., Nakagawa, K., Tanigawa, T., & Hida, E.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-29
- Volume
- 42
- Issue
- 40
- Pages
- 4111-4122
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W3198531566
- Cited by
- 228
- References
- 15
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehab559
- The paper
- Kario, K., Nomura, A., Harada, N., Okura, A., Nakagawa, K., Tanigawa, T., & Hida, E. (2021). Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehab559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.